GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk

A cohort study in three Scandinavian countries found no significant increase in thyroid cancer risk with glucagon-like peptide 1 receptor agonists.

Related Keywords

Denmark ,Sweden ,Stockholm ,Norway ,Karolinska Institutet , ,Thyroid Cancer ,Thyroid Carcinoma ,Ancer Of The Thyroid ,Thyroid Disorder ,Thyroid Disease ,Thyroid Dysfunction ,Malignant Head And Neck Neoplasm ,Head And Neck Cancer ,Ead And Neck Cancer Hnc ,Papillary Carcinoma Of The Thyroid ,Papillary Thyroid Carcinoma ,Cancer Risk ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,Thyroid ,Glp 1 Receptor Agonists ,